메뉴 건너뛰기




Volumn 10, Issue 13, 2015, Pages 2063-2074

Nanomedicine delivers promising treatments for rheumatoid arthritis

Author keywords

chronic inflammation; enhanced permeability and retention; liposomes; nanomedicine; nanoparticles; rheumatoid arthritis

Indexed keywords

ANGIOGENESIS INHIBITOR; BIOLOGICAL PRODUCT; CELL RECEPTOR; CORTICOSTEROID; DNA TOPOISOMERASE INHIBITOR; FOLIC ACID ANTAGONIST; GAMMA SECRETASE INHIBITOR; GOLD DERIVATIVE; IMMUNOMODULATING AGENT; NANOCARRIER; NANOPARTICLE; NONSTEROID ANTIINFLAMMATORY AGENT;

EID: 84937501117     PISSN: 17435889     EISSN: 17486963     Source Type: Journal    
DOI: 10.2217/nnm.15.45     Document Type: Review
Times cited : (112)

References (100)
  • 1
    • 84862915330 scopus 로고    scopus 로고
    • Regulation of the inflammatory response: Enhancing neutrophil infiltration under chronic inflammatory conditions
    • Bian Z, Guo Y, Ha B, Zen K, Liu Y. Regulation of the inflammatory response: enhancing neutrophil infiltration under chronic inflammatory conditions. J. Immunol. 188(2), 844-853 (2012).
    • (2012) J. Immunol. , vol.188 , Issue.2 , pp. 844-853
    • Bian, Z.1    Guo, Y.2    Ha, B.3    Zen, K.4    Liu, Y.5
  • 2
    • 0032519925 scopus 로고    scopus 로고
    • Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGFbeta, PGE2, and PAF
    • Fadok VA, Bratton DL, Konowal A, Freed PW, Westcott JY, Henson PM. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGFbeta, PGE2, and PAF. J. Clin. Invest. 101(4), 890-898 (1998).
    • (1998) J. Clin. Invest. , vol.101 , Issue.4 , pp. 890-898
    • Fadok, V.A.1    Bratton, D.L.2    Konowal, A.3    Freed, P.W.4    Westcott, J.Y.5    Henson, P.M.6
  • 3
    • 0035877019 scopus 로고    scopus 로고
    • Peripheral blood fibrocytes: Differentiation pathway and migration to wound sites
    • Abe R, Donnelly SC, Peng T, Bucala R, Metz CN. Peripheral blood fibrocytes: differentiation pathway and migration to wound sites. J. Immunol. 166(12), 7556-7562 (2001).
    • (2001) J. Immunol. , vol.166 , Issue.12 , pp. 7556-7562
    • Abe, R.1    Donnelly, S.C.2    Peng, T.3    Bucala, R.4    Metz, C.N.5
  • 5
    • 54349096867 scopus 로고    scopus 로고
    • Cytokines mediating the induction of chronic colitis and colitis-associated fibrosis
    • Fichtner-Feigl S, Strober W, Geissler EK, Schlitt HJ. Cytokines mediating the induction of chronic colitis and colitis-associated fibrosis. Mucosal Immunol. 1, S24-S27 (2008).
    • (2008) Mucosal Immunol. , vol.1 , pp. S24-S27
    • Fichtner-Feigl, S.1    Strober, W.2    Geissler, E.K.3    Schlitt, H.J.4
  • 6
    • 66549126476 scopus 로고    scopus 로고
    • Neutrophil apoptosis and the resolution of infection
    • Kennedy A, Deleo F. Neutrophil apoptosis and the resolution of infection. Immunol. Res. 43(1-3), 25-61 (2009).
    • (2009) Immunol. Res. , vol.43 , Issue.1-3 , pp. 25-61
    • Kennedy, A.1    Deleo, F.2
  • 7
    • 67449168081 scopus 로고    scopus 로고
    • Disruption of Nrf2 Impairs the resolution of hyperoxia-induced acute lung injury and inflammation in mice
    • Reddy NM, Kleeberger SR, Kensler TW, Yamamoto M, Hassoun PM, Reddy SP. Disruption of Nrf2 Impairs the resolution of hyperoxia-induced acute lung injury and inflammation in mice. J. Immunol. 182(11), 7264-7271 (2009).
    • (2009) J. Immunol. , vol.182 , Issue.11 , pp. 7264-7271
    • Reddy, N.M.1    Kleeberger, S.R.2    Kensler, T.W.3    Yamamoto, M.4    Hassoun, P.M.5    Reddy, S.P.6
  • 8
    • 84855172814 scopus 로고    scopus 로고
    • The pathogenesis of rheumatoid arthritis
    • Mcinnes IB, Schett G. The pathogenesis of rheumatoid arthritis. N. Engl. J. Med. 365(23), 2205-2219 (2011).
    • (2011) N. Engl. J. Med. , vol.365 , Issue.23 , pp. 2205-2219
    • Mcinnes, I.B.1    Schett, G.2
  • 9
    • 33745775434 scopus 로고    scopus 로고
    • Mechanisms of disease: Pathogenesis of Crohn's disease and ulcerative colitis
    • Sartor RB. Mechanisms of disease: pathogenesis of Crohn's disease and ulcerative colitis. Nat. Clin. Pract. Gastroenterol. Hepatol. 3, 390-407 (2006).
    • (2006) Nat. Clin. Pract. Gastroenterol. Hepatol. , vol.3 , pp. 390-407
    • Sartor, R.B.1
  • 10
    • 84864776533 scopus 로고    scopus 로고
    • Pathogenesis of chronic obstructive pulmonary disease
    • Tuder RM, Petrache I. Pathogenesis of chronic obstructive pulmonary disease. J. Clin. Invest. 122(8), 2749-2755 (2012).
    • (2012) J. Clin. Invest. , vol.122 , Issue.8 , pp. 2749-2755
    • Tuder, R.M.1    Petrache, I.2
  • 11
    • 77957196913 scopus 로고    scopus 로고
    • Rheumatoid arthritis
    • Scott DL, Wolfe F, Huizinga TWJ. Rheumatoid arthritis. Lancet 376(9746), 1094-1108 (2010).
    • (2010) Lancet , vol.376 , Issue.9746 , pp. 1094-1108
    • Scott, D.L.1    Wolfe, F.2    Huizinga, T.W.J.3
  • 12
    • 0033951612 scopus 로고    scopus 로고
    • Economic burden of rheumatoid arthritis: A systematic review
    • Cooper NJ. Economic burden of rheumatoid arthritis: a systematic review. Rheumatology (Oxford) 39(1), 28-33 (2000).
    • (2000) Rheumatology (Oxford) , vol.39 , Issue.1 , pp. 28-33
    • Cooper, N.J.1
  • 13
    • 79958835184 scopus 로고    scopus 로고
    • Inflammatory bowel disease-attributable costs and cost-effective strategies in the United States: A review
    • Park KT, Bass D. Inflammatory bowel disease-attributable costs and cost-effective strategies in the United States: a review. Inflammat. Bowel Dis. 17(7), 1603-1609 (2011).
    • (2011) Inflammat. Bowel Dis. , vol.17 , Issue.7 , pp. 1603-1609
    • Park, K.T.1    Bass, D.2
  • 14
    • 0037440789 scopus 로고    scopus 로고
    • Costs and predictors of costs in rheumatoid arthritis: A prevalence-based study
    • Lajas C, Abasolo L, Bellajdel B et al. Costs and predictors of costs in rheumatoid arthritis: a prevalence-based study. Arthritis Care Res. 49(1), 64-70 (2003).
    • (2003) Arthritis Care Res. , vol.49 , Issue.1 , pp. 64-70
    • Lajas, C.1    Abasolo, L.2    Bellajdel, B.3
  • 15
    • 79958076320 scopus 로고    scopus 로고
    • Health care costs and their predictors of inflammatory bowel diseases in Germany
    • Prenzler A, Bokemeyer B, Schulenburg JM, Mittendorf T. Health care costs and their predictors of inflammatory bowel diseases in Germany. Eur. J. Health Econ. 12(3), 273-283 (2011).
    • (2011) Eur. J. Health Econ. , vol.12 , Issue.3 , pp. 273-283
    • Prenzler, A.1    Bokemeyer, B.2    Schulenburg, J.M.3    Mittendorf, T.4
  • 16
    • 84856012240 scopus 로고    scopus 로고
    • Socioeconomic burden of immune-mediated inflammatory diseases-focusing on work productivity and disability
    • Jacobs P, Bissonnette R, Guenther LC. Socioeconomic burden of immune-mediated inflammatory diseases-focusing on work productivity and disability. J. Rheumatol. 88, 55-61 (2011).
    • (2011) J. Rheumatol. , vol.88 , pp. 55-61
    • Jacobs, P.1    Bissonnette, R.2    Guenther, L.C.3
  • 18
    • 0036680727 scopus 로고    scopus 로고
    • Batch and continuous fluid bed coating-review and state of the art
    • Teunou E, Poncelet D. Batch and continuous fluid bed coating-review and state of the art. J. Food Eng. 53(4), 325-340 (2002).
    • (2002) J. Food Eng. , vol.53 , Issue.4 , pp. 325-340
    • Teunou, E.1    Poncelet, D.2
  • 19
    • 85046075253 scopus 로고    scopus 로고
    • Rose NR, Mackay IR (Eds). Elsevier/Academic Press, Amsterdam, The Netherlands
    • Smolen JS, Redlich K. The Autoimmune Diseases (5th Edition). Rose NR, Mackay IR (Eds). Elsevier/Academic Press, Amsterdam, The Netherlands, 511-523 (2006).
    • (2006) The Autoimmune Diseases (5th Edition) , pp. 511-523
    • Smolen, J.S.1    Redlich, K.2
  • 20
  • 21
    • 34248207245 scopus 로고    scopus 로고
    • Monoclonal antibody and intravenous immunoglobulin therapy for rheumatic diseases: Rationale and mechanisms of action
    • Bayry J, Kaveri SV, Kazatchkine MD, Lacroix-Desmazes S. Monoclonal antibody and intravenous immunoglobulin therapy for rheumatic diseases: rationale and mechanisms of action. Nat. Clin. Pract. Rheumatol. 3(5), 262-272 (2007).
    • (2007) Nat. Clin. Pract. Rheumatol. , vol.3 , Issue.5 , pp. 262-272
    • Bayry, J.1    Kaveri, S.V.2    Kazatchkine, M.D.3    Lacroix-Desmazes, S.4
  • 23
    • 10344255627 scopus 로고    scopus 로고
    • Signal transduction pathways: New targets for treating rheumatoid arthritis
    • Morel J, Berenbaum F. Signal transduction pathways: new targets for treating rheumatoid arthritis. Joint Bone Spine 71(6), 503-510 (2004).
    • (2004) Joint Bone Spine , vol.71 , Issue.6 , pp. 503-510
    • Morel, J.1    Berenbaum, F.2
  • 24
    • 59649114148 scopus 로고    scopus 로고
    • Evaluation of the efficacy and safety of pamapimod, a p38 MAP kinase inhibitor, in a double-blind, methotrexate-controlled study of patients with active rheumatoid arthritis
    • Cohen SB, Cheng T-T, Chindalore V et al. Evaluation of the efficacy and safety of pamapimod, a p38 MAP kinase inhibitor, in a double-blind, methotrexate-controlled study of patients with active rheumatoid arthritis. Arthritis Rheumat. 60(2), 335-344 (2009).
    • (2009) Arthritis Rheumat. , vol.60 , Issue.2 , pp. 335-344
    • Cohen, S.B.1    Cheng, T.-T.2    Chindalore, V.3
  • 25
    • 55849114400 scopus 로고    scopus 로고
    • Treatment of rheumatoid arthritis with a Syk kinase inhibitor: A twelve-week, randomized, placebo-controlled trial
    • Weinblatt ME, Kavanaugh A, Burgos-Vargas R et al. Treatment of rheumatoid arthritis with a Syk kinase inhibitor: a twelve-week, randomized, placebo-controlled trial. Arthritis Rheumat. 58(11), 3309-3318 (2008).
    • (2008) Arthritis Rheumat. , vol.58 , Issue.11 , pp. 3309-3318
    • Weinblatt, M.E.1    Kavanaugh, A.2    Burgos-Vargas, R.3
  • 26
    • 81855170441 scopus 로고    scopus 로고
    • Nanomedicine(s) under the microscope
    • Duncan R, Gaspar R. Nanomedicine(s) under the microscope. Mol. Pharm. 8(6), 2101-2141 (2011).
    • (2011) Mol. Pharm. , vol.8 , Issue.6 , pp. 2101-2141
    • Duncan, R.1    Gaspar, R.2
  • 27
    • 1942423636 scopus 로고    scopus 로고
    • A transient diffusion model yields unitary gap junctional permeabilities from images of cell-to-cell fluorescent dye transfer between xenopus oocytes
    • Nitsche JM, Chang H-C, Weber PA, Nicholson BJ. A transient diffusion model yields unitary gap junctional permeabilities from images of cell-to-cell fluorescent dye transfer between xenopus oocytes. Biophys. J. 86(4), 2058-2077 (2004).
    • (2004) Biophys. J. , vol.86 , Issue.4 , pp. 2058-2077
    • Nitsche, J.M.1    Chang, H.-C.2    Weber, P.A.3    Nicholson, B.J.4
  • 28
    • 1942485065 scopus 로고    scopus 로고
    • The permeability of gap junction channels to probes of different size is dependent on connexin composition and permeant-pore affinities
    • Weber PA, Chang H-C, Spaeth KE, Nitsche JM, Nicholson BJ. The permeability of gap junction channels to probes of different size is dependent on connexin composition and permeant-pore affinities. Biophys. J. 87(2), 958-973 (2004).
    • (2004) Biophys. J. , vol.87 , Issue.2 , pp. 958-973
    • Weber, P.A.1    Chang, H.-C.2    Spaeth, K.E.3    Nitsche, J.M.4    Nicholson, B.J.5
  • 29
    • 0032103164 scopus 로고    scopus 로고
    • Gap junction channels in the cardiovascular system: Pharmacological and physiological modulation
    • Dhein S. Gap junction channels in the cardiovascular system: pharmacological and physiological modulation. Trends Pharmacol. Sci. 19(6), 229-241 (1998).
    • (1998) Trends Pharmacol. Sci. , vol.19 , Issue.6 , pp. 229-241
    • Dhein, S.1
  • 30
    • 0014097086 scopus 로고
    • Hexagonal array of subunits in intercellular junctions of the mouse heart and liver
    • Revel JP, Karnovsky MJ. Hexagonal array of subunits in intercellular junctions of the mouse heart and liver. J. Cell Biol. 33(3), C7-C12 (1967).
    • (1967) J. Cell Biol. , vol.33 , Issue.3 , pp. C7-C12
    • Revel, J.P.1    Karnovsky, M.J.2
  • 31
    • 0034993240 scopus 로고    scopus 로고
    • The enhanced permeability and retention (EPR) effect in tumor vasculature: The key role of tumor-selective macromolecular drug targeting
    • Maeda H. The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting. Adv. Enzyme Regul. 41(1), 189-207 (2001).
    • (2001) Adv. Enzyme Regul. , vol.41 , Issue.1 , pp. 189-207
    • Maeda, H.1
  • 32
    • 0029150245 scopus 로고
    • Vascular permeability in a human tumor xenograft: Molecular size dependence and cutoff size
    • Yuan F, Dellian M, Fukumura D et al. Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size. Cancer Res. 55(17), 3752-3756 (1995).
    • (1995) Cancer Res. , vol.55 , Issue.17 , pp. 3752-3756
    • Yuan, F.1    Dellian, M.2    Fukumura, D.3
  • 33
    • 84937398939 scopus 로고    scopus 로고
    • Kumar A, Mansour HM, Friedman A, Blough ER (Eds). CRC Press/Taylor & Francis Group, FL, USA
    • Castro E, Kumar A. Nanomedicine in Drug Delivery. Kumar A, Mansour HM, Friedman A, Blough ER (Eds). CRC Press/Taylor & Francis Group, FL, USA, 1-22 (2013).
    • (2013) Nanomedicine in Drug Delivery , pp. 1-22
    • Castro, E.1    Kumar, A.2
  • 35
    • 77952220675 scopus 로고    scopus 로고
    • Protein PEGylation, basic science and biological applications
    • Veronese F (Ed.). Birkhäuser Verlag, Basel, Switzerland
    • Veronese F, Mero A, Pasut G. Protein PEGylation, basic science and biological applications. In: PEGylated Protein Drugs: Basic Science and Clinical Applications. Veronese F (Ed.). Birkhäuser Verlag, Basel, Switzerland, 11-31 (2009).
    • (2009) PEGylated Protein Drugs: Basic Science and Clinical Applications , pp. 11-31
    • Veronese, F.1    Mero, A.2    Pasut, G.3
  • 36
    • 0035005359 scopus 로고    scopus 로고
    • PEGylated liposomal doxorubicin: Metamorphosis of an old drug into a new form of chemotherapy
    • Gabizon AA. PEGylated liposomal doxorubicin: metamorphosis of an old drug into a new form of chemotherapy. Cancer Invest. 19(4), 424-436 (2001).
    • (2001) Cancer Invest. , vol.19 , Issue.4 , pp. 424-436
    • Gabizon, A.A.1
  • 37
    • 77952575335 scopus 로고    scopus 로고
    • Tumor-selective delivery of macromolecular drugs via the EPR effect: Background and future prospects
    • Maeda H. Tumor-selective delivery of macromolecular drugs via the EPR effect: background and future prospects. Bioconjug. Chem. 21(5), 797-802 (2010).
    • (2010) Bioconjug. Chem. , vol.21 , Issue.5 , pp. 797-802
    • Maeda, H.1
  • 38
    • 84880757123 scopus 로고    scopus 로고
    • The link between infection and cancer: Tumor vasculature, free radicals, and drug delivery to tumors via the EPR effect
    • Maeda H. The link between infection and cancer: tumor vasculature, free radicals, and drug delivery to tumors via the EPR effect. Cancer Sci. 104(7), 779-789 (2013).
    • (2013) Cancer Sci. , vol.104 , Issue.7 , pp. 779-789
    • Maeda, H.1
  • 39
    • 84856661263 scopus 로고    scopus 로고
    • Studies on the cell biology of interendothelial cell gaps
    • Ochoa CD, Stevens T. Studies on the cell biology of interendothelial cell gaps. Am. J. Physiol. 302(3), L275-L286 (2012).
    • (2012) Am. J. Physiol. , vol.302 , Issue.3 , pp. L275-L286
    • Ochoa, C.D.1    Stevens, T.2
  • 40
    • 74549156006 scopus 로고    scopus 로고
    • Chemokines and cytokines in inflammatory angiogenesis
    • Seed M, Walsh D (Eds). Birkhäuser Verlag, Basel, Switzerland
    • Szekanecz Z, Koch A. Chemokines and cytokines in inflammatory angiogenesis. In: Angiogenesis in Inflammation: Mechanisms and Clinical Correlates. Seed M, Walsh D (Eds). Birkhäuser Verlag, Basel, Switzerland, 83-98 (2008).
    • (2008) Angiogenesis in Inflammation: Mechanisms and Clinical Correlates , pp. 83-98
    • Szekanecz, Z.1    Koch, A.2
  • 41
    • 0033063325 scopus 로고    scopus 로고
    • VCAM-1 and ICAM-1 mediate leukocyte-endothelial cell adhesion in rat experimental colitis
    • Sans M, Panés J, Ardite E et al. VCAM-1 and ICAM-1 mediate leukocyte-endothelial cell adhesion in rat experimental colitis. Gastroenterology 116(4), 874-883 (1999).
    • (1999) Gastroenterology , vol.116 , Issue.4 , pp. 874-883
    • Sans, M.1    Panés, J.2    Ardite, E.3
  • 42
    • 79955619445 scopus 로고    scopus 로고
    • Actively targeted lowdose camptothecin as a safe, long-acting, disease-modifying nanomedicine for rheumatoid arthritis
    • Koo O, Rubinstein I, Önyüksel H. Actively targeted lowdose camptothecin as a safe, long-acting, disease-modifying nanomedicine for rheumatoid arthritis. Pharm. Res. 28(4), 776-787 (2011).
    • (2011) Pharm. Res. , vol.28 , Issue.4 , pp. 776-787
    • Koo, O.1    Rubinstein, I.2    Önyüksel, H.3
  • 43
    • 77955409183 scopus 로고    scopus 로고
    • Liposome-bound APO2L/TRAIL is an effective treatment in a rabbit model of rheumatoid arthritis
    • Martinez-Lostao L, Garcia-Alvarez F, Basanez G et al. Liposome-bound APO2L/TRAIL is an effective treatment in a rabbit model of rheumatoid arthritis. Arthritis Rheumat. 62(8), 2272-2282 (2010).
    • (2010) Arthritis Rheumat. , vol.62 , Issue.8 , pp. 2272-2282
    • Martinez-Lostao, L.1    Garcia-Alvarez, F.2    Basanez, G.3
  • 44
    • 85015549976 scopus 로고    scopus 로고
    • ClinicalTrials.gov. www.clinicaltrials.gov
  • 45
    • 84875493753 scopus 로고    scopus 로고
    • Cytoprotective and enhanced anti-inflammatory activities of liposomal piroxicam formulation in lipopolysaccharide-stimulated RAW 264.7 macrophages
    • Chiong HS, Yong YK, Ahmad Z et al. Cytoprotective and enhanced anti-inflammatory activities of liposomal piroxicam formulation in lipopolysaccharide-stimulated RAW 264.7 macrophages. Int. J. Nanomedicine 8, 1245-1255 (2013).
    • (2013) Int. J. Nanomedicine , vol.8 , pp. 1245-1255
    • Chiong, H.S.1    Yong, Y.K.2    Ahmad, Z.3
  • 46
    • 84893749660 scopus 로고    scopus 로고
    • Formulation and optimization of nonionic surfactants emulsified nimesulide-loaded PLGA-based nanoparticles by design of experiments
    • Turk CTS, Oz UC, Serim TM, Hascicek C. Formulation and optimization of nonionic surfactants emulsified nimesulide-loaded PLGA-based nanoparticles by design of experiments. AAPS PharmSciTech 15(1), 161-176 (2014).
    • (2014) AAPS PharmSciTech , vol.15 , Issue.1 , pp. 161-176
    • Turk, C.T.S.1    Oz, U.C.2    Serim, T.M.3    Hascicek, C.4
  • 47
    • 84908281062 scopus 로고    scopus 로고
    • An investigation into the interactions of gold nanoparticles and anti-arthritic drugs with macrophages, and their reactivity towards thioredoxin reductase
    • James LRA, Xu Z-Q, Sluyter R et al. An investigation into the interactions of gold nanoparticles and anti-arthritic drugs with macrophages, and their reactivity towards thioredoxin reductase. J. Inorg. Biochem. 142(0), 28-38 (2015).
    • (2015) J. Inorg. Biochem. , vol.142 , pp. 28-38
    • James, L.R.A.1    Xu, Z.-Q.2    Sluyter, R.3
  • 48
    • 79958207519 scopus 로고    scopus 로고
    • Intravenously delivered glucocorticoid liposomes inhibit osteoclast activity and bone erosion in murine antigen-induced arthritis
    • Hofkens W, Grevers LC, Walgreen B et al. Intravenously delivered glucocorticoid liposomes inhibit osteoclast activity and bone erosion in murine antigen-induced arthritis. J. Control. Release 152(3), 363-369 (2011).
    • (2011) J. Control. Release , vol.152 , Issue.3 , pp. 363-369
    • Hofkens, W.1    Grevers, L.C.2    Walgreen, B.3
  • 49
    • 79961062552 scopus 로고    scopus 로고
    • Liposomal targeting of glucocorticoids to the inflamed synovium inhibits cartilage matrix destruction during murine antigen-induced arthritis
    • Hofkens W, Storm G, Van Den Berg WB, Van Lent PL. Liposomal targeting of glucocorticoids to the inflamed synovium inhibits cartilage matrix destruction during murine antigen-induced arthritis. Int. J. Pharm. 416(2), 486-492 (2011).
    • (2011) Int. J. Pharm. , vol.416 , Issue.2 , pp. 486-492
    • Hofkens, W.1    Storm, G.2    Van Den Berg, W.B.3    Van Lent, P.L.4
  • 50
    • 80051904807 scopus 로고    scopus 로고
    • Safety of glucocorticoids can be improved by lower yet still effective dosages of liposomal steroid formulations in murine antigen-induced arthritis: Comparison of prednisolone with budesonide
    • Hofkens W, Van Den Hoven JM, Pesman GJ et al. Safety of glucocorticoids can be improved by lower yet still effective dosages of liposomal steroid formulations in murine antigen-induced arthritis: comparison of prednisolone with budesonide. Int. J. Pharm. 416(2), 493-498 (2011).
    • (2011) Int. J. Pharm. , vol.416 , Issue.2 , pp. 493-498
    • Hofkens, W.1    Van Den Hoven, J.M.2    Pesman, G.J.3
  • 51
    • 84874522489 scopus 로고    scopus 로고
    • Liposomal targeting of prednisolone phosphate to synovial lining macrophages during experimental arthritis inhibits M1 activation but does not favor M2 differentiation
    • Hofkens W, Schelbergen R, Storm G, Van Den Berg WB, Van Lent PL. Liposomal targeting of prednisolone phosphate to synovial lining macrophages during experimental arthritis inhibits M1 activation but does not favor M2 differentiation. PLoS ONE 8(2), e54016 (2013).
    • (2013) PLoS ONE , vol.8 , Issue.2 , pp. e54016
    • Hofkens, W.1    Schelbergen, R.2    Storm, G.3    Van Den Berg, W.B.4    Van Lent, P.L.5
  • 52
    • 1842505688 scopus 로고    scopus 로고
    • Liposomal targeting of glucocorticoids to synovial lining cells strongly increases therapeutic benefit in collagen type II arthritis
    • Metselaar JM, Van Den Berg WB, Holthuysen AE, Wauben MH, Storm G, Van Lent PL. Liposomal targeting of glucocorticoids to synovial lining cells strongly increases therapeutic benefit in collagen type II arthritis. Ann. Rheumat. Dis. 63(4), 348-353 (2004).
    • (2004) Ann. Rheumat. Dis. , vol.63 , Issue.4 , pp. 348-353
    • Metselaar, J.M.1    Van Den Berg, W.B.2    Holthuysen, A.E.3    Wauben, M.H.4    Storm, G.5    Van Lent, P.L.6
  • 53
    • 84861660607 scopus 로고    scopus 로고
    • Glucocorticoids in nano-liposomes administered intravenously and subcutaneously to adjuvant arthritis rats are superior to the free drugs in suppressing arthritis and inflammatory cytokines
    • Ulmansky R, Turjeman K, Baru M et al. Glucocorticoids in nano-liposomes administered intravenously and subcutaneously to adjuvant arthritis rats are superior to the free drugs in suppressing arthritis and inflammatory cytokines. J. Control. Release 160(2), 299-305 (2012).
    • (2012) J. Control. Release , vol.160 , Issue.2 , pp. 299-305
    • Ulmansky, R.1    Turjeman, K.2    Baru, M.3
  • 54
    • 38149100039 scopus 로고    scopus 로고
    • Amphipathic weak acid glucocorticoid prodrugs remote-loaded into sterically stabilized nanoliposomes evaluated in arthritic rats and in a Beagle dog: A novel approach to treating autoimmune arthritis
    • Avnir Y, Ulmansky R, Wasserman V et al. Amphipathic weak acid glucocorticoid prodrugs remote-loaded into sterically stabilized nanoliposomes evaluated in arthritic rats and in a Beagle dog: a novel approach to treating autoimmune arthritis. Arthritis Rheumat. 58(1), 119-129 (2008).
    • (2008) Arthritis Rheumat. , vol.58 , Issue.1 , pp. 119-129
    • Avnir, Y.1    Ulmansky, R.2    Wasserman, V.3
  • 55
    • 58849104833 scopus 로고    scopus 로고
    • Alphamethylprednisolone conjugated cyclodextrin polymer-based nanoparticles for rheumatoid arthritis therapy
    • Hwang J, Rodgers K, Oliver JC, Schluep T. Alphamethylprednisolone conjugated cyclodextrin polymer-based nanoparticles for rheumatoid arthritis therapy. Int. J. Nanomedicine 3(3), 359-371 (2008).
    • (2008) Int. J. Nanomedicine , vol.3 , Issue.3 , pp. 359-371
    • Hwang, J.1    Rodgers, K.2    Oliver, J.C.3    Schluep, T.4
  • 56
    • 65649115761 scopus 로고    scopus 로고
    • Treatment of experimental arthritis with stealth-type polymeric nanoparticles encapsulating betamethasone phosphate
    • Ishihara T, Kubota T, Choi T, Higaki M. Treatment of experimental arthritis with stealth-type polymeric nanoparticles encapsulating betamethasone phosphate. J. Pharm. Exp. Ther. 329(2), 412-417 (2009).
    • (2009) J. Pharm. Exp. Ther. , vol.329 , Issue.2 , pp. 412-417
    • Ishihara, T.1    Kubota, T.2    Choi, T.3    Higaki, M.4
  • 57
    • 77954671356 scopus 로고    scopus 로고
    • Liposomal encapsulation enhances and prolongs the anti-inflammatory effects of water-soluble dexamethasone phosphate in experimental adjuvant arthritis
    • Anderson R, Franch A, Castell M et al. Liposomal encapsulation enhances and prolongs the anti-inflammatory effects of water-soluble dexamethasone phosphate in experimental adjuvant arthritis. Arthritis Res. Ther. 12(4), R147 (2010).
    • (2010) Arthritis Res. Ther. , vol.12 , Issue.4 , pp. R147
    • Anderson, R.1    Franch, A.2    Castell, M.3
  • 58
    • 77952539277 scopus 로고    scopus 로고
    • Separating therapeutic efficacy from glucocorticoid side-effects in rodent arthritis using novel, liposomal delivery of dexamethasone phosphate: Long-term suppression of arthritis facilitates interval treatment
    • Rauchhaus U, Schwaiger FW, Panzner S. Separating therapeutic efficacy from glucocorticoid side-effects in rodent arthritis using novel, liposomal delivery of dexamethasone phosphate: long-term suppression of arthritis facilitates interval treatment. Arthritis Res. Ther. 11(6), R190 (2009).
    • (2009) Arthritis Res. Ther. , vol.11 , Issue.6 , pp. R190
    • Rauchhaus, U.1    Schwaiger, F.W.2    Panzner, S.3
  • 59
    • 33646381864 scopus 로고    scopus 로고
    • Targeting of angiogenic endothelial cells at sites of inflammation by dexamethasone phosphate-containing RGD peptide liposomes inhibits experimental arthritis
    • Koning GA, Schiffelers RM, Wauben MH et al. Targeting of angiogenic endothelial cells at sites of inflammation by dexamethasone phosphate-containing RGD peptide liposomes inhibits experimental arthritis. Arthritis Rheumat. 54(4), 1198-1208 (2006).
    • (2006) Arthritis Rheumat. , vol.54 , Issue.4 , pp. 1198-1208
    • Koning, G.A.1    Schiffelers, R.M.2    Wauben, M.H.3
  • 60
    • 84893472683 scopus 로고    scopus 로고
    • Nanomedicines for inflammatory arthritis: Head-to-head comparison of glucocorticoid-containing polymers, micelles, and liposomes
    • Quan L, Zhang Y, Crielaard BJ et al. Nanomedicines for inflammatory arthritis: head-to-head comparison of glucocorticoid-containing polymers, micelles, and liposomes. ACS Nano 8(1), 458-466 (2013).
    • (2013) ACS Nano , vol.8 , Issue.1 , pp. 458-466
    • Quan, L.1    Zhang, Y.2    Crielaard, B.J.3
  • 61
    • 84905250766 scopus 로고    scopus 로고
    • Liposomal encapsulation of dexamethasone modulates cytotoxicity, inflammatory cytokine response, and migratory properties of primary human macrophages
    • Bartneck M, Peters FM, Warzecha KT et al. Liposomal encapsulation of dexamethasone modulates cytotoxicity, inflammatory cytokine response, and migratory properties of primary human macrophages. Nanomedicine 10(6), 1209-1220 (2014).
    • (2014) Nanomedicine , vol.10 , Issue.6 , pp. 1209-1220
    • Bartneck, M.1    Peters, F.M.2    Warzecha, K.T.3
  • 62
    • 80052323457 scopus 로고    scopus 로고
    • Folatetargeted nanoparticles show efficacy in the treatment of inflammatory arthritis
    • Thomas TP, Goonewardena SN, Majoros IJ et al. Folatetargeted nanoparticles show efficacy in the treatment of inflammatory arthritis. Arthritis Rheumat. 63(9), 2671-2680 (2011).
    • (2011) Arthritis Rheumat. , vol.63 , Issue.9 , pp. 2671-2680
    • Thomas, T.P.1    Goonewardena, S.N.2    Majoros, I.J.3
  • 63
    • 84873944529 scopus 로고    scopus 로고
    • Intra-articular methotrexate associated to lipid nanoemulsions: Anti-inflammatory effect upon antigeninduced arthritis
    • Mello SB, Tavares ER, Bulgarelli A, Bonfa E, Maranhao RC. Intra-articular methotrexate associated to lipid nanoemulsions: anti-inflammatory effect upon antigeninduced arthritis. Int. J. Nanomedicine 8, 443-449 (2013).
    • (2013) Int. J. Nanomedicine , vol.8 , pp. 443-449
    • Mello, S.B.1    Tavares, E.R.2    Bulgarelli, A.3    Bonfa, E.4    Maranhao, R.C.5
  • 64
    • 84922838408 scopus 로고    scopus 로고
    • Co-association of methotrexate and SPIONs into anti-CD64 antibody-conjugated PLGA nanoparticles for theranostic application
    • Moura CC, Segundo MA, Neves JD, Reis S, Sarmento B. Co-association of methotrexate and SPIONs into anti-CD64 antibody-conjugated PLGA nanoparticles for theranostic application. Int. J. Nanomedicine 9, 4911-4922 (2014).
    • (2014) Int. J. Nanomedicine , vol.9 , pp. 4911-4922
    • Moura, C.C.1    Segundo, M.A.2    Neves, J.D.3    Reis, S.4    Sarmento, B.5
  • 65
    • 84902139466 scopus 로고    scopus 로고
    • Sequential optimization of methotrexate encapsulation in micellar nano-networks of polyethyleneimine ionomer containing redox-sensitive crosslinks
    • Abolmaali SS, Tamaddon A, Yousefi G, Javidnia K, Dinarvand R. Sequential optimization of methotrexate encapsulation in micellar nano-networks of polyethyleneimine ionomer containing redox-sensitive crosslinks. Int. J. Nanomedicine 9, 2833-2848 (2014).
    • (2014) Int. J. Nanomedicine , vol.9 , pp. 2833-2848
    • Abolmaali, S.S.1    Tamaddon, A.2    Yousefi, G.3    Javidnia, K.4    Dinarvand, R.5
  • 66
    • 84919631363 scopus 로고    scopus 로고
    • Sugarcane bagasse lignin, and silica gel and magneto-silica as drug vehicles for development of innocuous methotrexate drug against rheumatoid arthritis disease in albino rats
    • Wahba SMR, Darwish AS, Shehata IH, Abd Elhalem SS. Sugarcane bagasse lignin, and silica gel and magneto-silica as drug vehicles for development of innocuous methotrexate drug against rheumatoid arthritis disease in albino rats. Mat. Sci. Eng. C 48, 599-610 (2015).
    • (2015) Mat. Sci. Eng. C , vol.48 , pp. 599-610
    • Wahba, S.M.R.1    Darwish, A.S.2    Shehata, I.H.3    Abd Elhalem, S.S.4
  • 67
    • 84885365131 scopus 로고    scopus 로고
    • Synthesis and evaluation of cyclosporine A-loaded polysialic acid-polycaprolactone micelles for rheumatoid arthritis
    • Wilson DR, Zhang N, Silvers AL, Forstner MB, Bader RA. Synthesis and evaluation of cyclosporine A-loaded polysialic acid-polycaprolactone micelles for rheumatoid arthritis. Eur. J. Pharm. Sci. 51, 146-156 (2014).
    • (2014) Eur. J. Pharm. Sci. , vol.51 , pp. 146-156
    • Wilson, D.R.1    Zhang, N.2    Silvers, A.L.3    Forstner, M.B.4    Bader, R.A.5
  • 68
    • 77957313563 scopus 로고    scopus 로고
    • Ionic complex systems based on hyaluronic acid and PEGylated TNF-related apoptosisinducing ligand for treatment of rheumatoid arthritis
    • Kim YJ, Chae SY, Jin CH et al. Ionic complex systems based on hyaluronic acid and PEGylated TNF-related apoptosisinducing ligand for treatment of rheumatoid arthritis. Biomaterials 31(34), 9057-9064 (2010).
    • (2010) Biomaterials , vol.31 , Issue.34 , pp. 9057-9064
    • Kim, Y.J.1    Chae, S.Y.2    Jin, C.H.3
  • 69
    • 84855845432 scopus 로고    scopus 로고
    • Co-delivery of antigen and a lipophilic antiinflammatory drug to cells via a tailorable nanocarrier emulsion
    • Chuan YP, Zeng BY, O'Sullivan B, Thomas R, Middelberg AP. Co-delivery of antigen and a lipophilic antiinflammatory drug to cells via a tailorable nanocarrier emulsion. J. Colloid Interface Sci. 368(1), 616-624 (2012).
    • (2012) J. Colloid Interface Sci. , vol.368 , Issue.1 , pp. 616-624
    • Chuan, Y.P.1    Zeng, B.Y.2    O'Sullivan, B.3    Thomas, R.4    Middelberg, A.P.5
  • 70
    • 84866181821 scopus 로고    scopus 로고
    • Suppression of inflammation in a mouse model of rheumatoid arthritis using targeted lipase-labile fumagillin prodrug nanoparticles
    • Zhou HF, Yan H, Senpan A et al. Suppression of inflammation in a mouse model of rheumatoid arthritis using targeted lipase-labile fumagillin prodrug nanoparticles. Biomaterials 33(33), 8632-8640 (2012).
    • (2012) Biomaterials , vol.33 , Issue.33 , pp. 8632-8640
    • Zhou, H.F.1    Yan, H.2    Senpan, A.3
  • 71
    • 84907229817 scopus 로고    scopus 로고
    • Hyaluronan nanoparticles bearing ?-secretase inhibitor: In vivo therapeutic effects on rheumatoid arthritis
    • Heo R, Park J-S, Jang HJ et al. Hyaluronan nanoparticles bearing ?-secretase inhibitor: in vivo therapeutic effects on rheumatoid arthritis. J. Control. Release 192, 295-300 (2014).
    • (2014) J. Control. Release , vol.192 , pp. 295-300
    • Heo, R.1    Park, J.-S.2    Jang, H.J.3
  • 72
    • 77950657693 scopus 로고    scopus 로고
    • Safety, tolerability, and clinical outcomes after intraarticular injection of a recombinant adeno-associated vector containing a tumor necrosis factor antagonist gene: Results of a Phase 1/2 study
    • Mease PJ, Wei N, Fudman EJ et al. Safety, tolerability, and clinical outcomes after intraarticular injection of a recombinant adeno-associated vector containing a tumor necrosis factor antagonist gene: results of a Phase 1/2 study. J. Rheumatol. 37(4), 692-703 (2010).
    • (2010) J. Rheumatol. , vol.37 , Issue.4 , pp. 692-703
    • Mease, P.J.1    Wei, N.2    Fudman, E.J.3
  • 73
    • 33846846570 scopus 로고    scopus 로고
    • Liposomes for phospholipase A2 triggered siRNA release: Preparation and in vitro test
    • Foged C, Nielsen HM, Frokjaer S. Liposomes for phospholipase A2 triggered siRNA release: preparation and in vitro test. Int. J. Pharm. 331(2), 160-166 (2007).
    • (2007) Int. J. Pharm. , vol.331 , Issue.2 , pp. 160-166
    • Foged, C.1    Nielsen, H.M.2    Frokjaer, S.3
  • 74
    • 58149215702 scopus 로고    scopus 로고
    • Chitosan/siRNA nanoparticlemediated TNF-alpha knockdown in peritoneal macrophages for anti-inflammatory treatment in a murine arthritis model
    • Howard KA, Paludan SR, Behlke MA, Besenbacher F, Deleuran B, Kjems J. Chitosan/siRNA nanoparticlemediated TNF-alpha knockdown in peritoneal macrophages for anti-inflammatory treatment in a murine arthritis model. Mol. Ther. 17(1), 162-168 (2009).
    • (2009) Mol. Ther. , vol.17 , Issue.1 , pp. 162-168
    • Howard, K.A.1    Paludan, S.R.2    Behlke, M.A.3    Besenbacher, F.4    Deleuran, B.5    Kjems, J.6
  • 75
    • 84055177973 scopus 로고    scopus 로고
    • Arthritic joint-targeting small interfering RNAencapsulated liposome: Implication for treatment strategy for rheumatoid arthritis
    • Komano Y, Yagi N, Onoue I, Kaneko K, Miyasaka N, Nanki T. Arthritic joint-targeting small interfering RNAencapsulated liposome: implication for treatment strategy for rheumatoid arthritis. J. Pharm. Exp. Ther. 340(1), 109-113 (2012).
    • (2012) J. Pharm. Exp. Ther. , vol.340 , Issue.1 , pp. 109-113
    • Komano, Y.1    Yagi, N.2    Onoue, I.3    Kaneko, K.4    Miyasaka, N.5    Nanki, T.6
  • 76
    • 33745014998 scopus 로고    scopus 로고
    • Efficient new cationic liposome formulation for systemic delivery of small interfering RNA silencing tumor necrosis factor alpha in experimental arthritis
    • Khoury M, Louis-Plence P, Escriou V et al. Efficient new cationic liposome formulation for systemic delivery of small interfering RNA silencing tumor necrosis factor alpha in experimental arthritis. Arthritis Rheumat. 54(6), 1867-1877 (2006).
    • (2006) Arthritis Rheumat. , vol.54 , Issue.6 , pp. 1867-1877
    • Khoury, M.1    Louis-Plence, P.2    Escriou, V.3
  • 77
    • 84864590087 scopus 로고    scopus 로고
    • MRIassessed therapeutic effects of locally administered PLGA nanoparticles loaded with anti-inflammatory siRNA in a murine arthritis model
    • Te Boekhorst BCM, Jensen LB, Colombo S et al. MRIassessed therapeutic effects of locally administered PLGA nanoparticles loaded with anti-inflammatory siRNA in a murine arthritis model. J. Control. Release 161(3), 772-780 (2012).
    • (2012) J. Control. Release , vol.161 , Issue.3 , pp. 772-780
    • Te Boekhorst, B.C.M.1    Jensen, L.B.2    Colombo, S.3
  • 78
    • 82455217419 scopus 로고    scopus 로고
    • Functionalized STAT1 siRNA nanoparticles regress rheumatoid arthritis in a mouse model
    • Scheinman RI, Trivedi R, Vermillion S, Kompella UB. Functionalized STAT1 siRNA nanoparticles regress rheumatoid arthritis in a mouse model. Nanomedicine 6(10), 1669-1682 (2011).
    • (2011) Nanomedicine , vol.6 , Issue.10 , pp. 1669-1682
    • Scheinman, R.I.1    Trivedi, R.2    Vermillion, S.3    Kompella, U.B.4
  • 79
    • 84892424496 scopus 로고    scopus 로고
    • Systemic delivery of small interfering RNA targeting the interleukin-2/15 receptor ? Chain prevents disease progression in experimental arthritis
    • Zhang T, Bai X, Mao X. Systemic delivery of small interfering RNA targeting the interleukin-2/15 receptor ? chain prevents disease progression in experimental arthritis. PLoS ONE 8(11), e78619 (2013).
    • (2013) PLoS ONE , vol.8 , Issue.11 , pp. e78619
    • Zhang, T.1    Bai, X.2    Mao, X.3
  • 80
    • 45749097402 scopus 로고    scopus 로고
    • Bone-protective effects of nonviral gene therapy with folate-chitosan DNA nanoparticle containing interleukin-1 receptor antagonist gene in rats with adjuvant-induced arthritis
    • Fernandes JC, Wang H, Jreyssaty C et al. Bone-protective effects of nonviral gene therapy with folate-chitosan DNA nanoparticle containing interleukin-1 receptor antagonist gene in rats with adjuvant-induced arthritis. Mol. Ther. 16(7), 1243-1251 (2008).
    • (2008) Mol. Ther. , vol.16 , Issue.7 , pp. 1243-1251
    • Fernandes, J.C.1    Wang, H.2    Jreyssaty, C.3
  • 81
    • 84881184459 scopus 로고    scopus 로고
    • Temperature-modulated noncovalent interaction controllable complex for the longterm delivery of etanercept to treat rheumatoid arthritis
    • Jung Y-S, Park W, Na K. Temperature-modulated noncovalent interaction controllable complex for the longterm delivery of etanercept to treat rheumatoid arthritis. J. Control. Release 171(2), 143-151 (2013).
    • (2013) J. Control. Release , vol.171 , Issue.2 , pp. 143-151
    • Jung, Y.-S.1    Park, W.2    Na, K.3
  • 82
    • 84873390528 scopus 로고    scopus 로고
    • Novel, Biocompatible, and disease modifying VIP nanomedicine for rheumatoid arthritis
    • Sethi V, Rubinstein I, Kuzmis A, Kastrissios H, Artwohl J, Onyuksel H. Novel, Biocompatible, and disease modifying VIP nanomedicine for rheumatoid arthritis. Mol. Pharm. 10(2), 728-738 (2012).
    • (2012) Mol. Pharm. , vol.10 , Issue.2 , pp. 728-738
    • Sethi, V.1    Rubinstein, I.2    Kuzmis, A.3    Kastrissios, H.4    Artwohl, J.5    Onyuksel, H.6
  • 83
    • 0033509413 scopus 로고    scopus 로고
    • Selective expression of folate receptor ? and its possible role in methotrexate transport in synovial macrophages from patients with rheumatoid arthritis
    • Nakashima-Matsushita N, Homma T, Yu S et al. Selective expression of folate receptor ? and its possible role in methotrexate transport in synovial macrophages from patients with rheumatoid arthritis. Arthritis Rheumat. 42(8), 1609-1616 (1999).
    • (1999) Arthritis Rheumat. , vol.42 , Issue.8 , pp. 1609-1616
    • Nakashima-Matsushita, N.1    Homma, T.2    Yu, S.3
  • 84
    • 0036174736 scopus 로고    scopus 로고
    • Inhibition of LFA-1/ICAM-1 and VLA-4/ VCAM-1 as a therapeutic approach to inflammation and autoimmune diseases
    • Yusuf-Makagiansar H, Anderson ME, Yakovleva TV, Murray JS, Siahaan TJ. Inhibition of LFA-1/ICAM-1 and VLA-4/ VCAM-1 as a therapeutic approach to inflammation and autoimmune diseases. Medicinal Res. Rev. 22(2), 146-167 (2002).
    • (2002) Medicinal Res. Rev. , vol.22 , Issue.2 , pp. 146-167
    • Yusuf-Makagiansar, H.1    Anderson, M.E.2    Yakovleva, T.V.3    Murray, J.S.4    Siahaan, T.J.5
  • 85
    • 23944515786 scopus 로고    scopus 로고
    • Endothelial intercellular adhesion molecule (ICAM)-2 regulates angiogenesis
    • Huang M-T, Mason JC, Birdsey GM et al. Endothelial intercellular adhesion molecule (ICAM)-2 regulates angiogenesis. Blood 106(5), 1636-1643 (2005).
    • (2005) Blood , vol.106 , Issue.5 , pp. 1636-1643
    • Huang, M.-T.1    Mason, J.C.2    Birdsey, G.M.3
  • 86
    • 79955911075 scopus 로고    scopus 로고
    • Human vascular endothelial cells: A model system for studying vascular inflammation in diabetes and atherosclerosis
    • Onat D, Brillon D, Colombo P, Schmidt A. Human vascular endothelial cells: a model system for studying vascular inflammation in diabetes and atherosclerosis. Curr. Diab. Rep. 11(3), 193-202 (2011).
    • (2011) Curr. Diab. Rep. , vol.11 , Issue.3 , pp. 193-202
    • Onat, D.1    Brillon, D.2    Colombo, P.3    Schmidt, A.4
  • 87
    • 0036166975 scopus 로고    scopus 로고
    • Vasoactive intestinal peptide in the immune system: Potential therapeutic role in inflammatory and autoimmune diseases
    • Delgado M, Abad C, Martinez C et al. Vasoactive intestinal peptide in the immune system: potential therapeutic role in inflammatory and autoimmune diseases. J. Mol. Med. 80(1), 16-24 (2002).
    • (2002) J. Mol. Med. , vol.80 , Issue.1 , pp. 16-24
    • Delgado, M.1    Abad, C.2    Martinez, C.3
  • 88
    • 55949094904 scopus 로고    scopus 로고
    • Current status of gene therapy for rheumatoid arthritis
    • Gaddy D, Robbins P. Current status of gene therapy for rheumatoid arthritis. Curr. Rheumatol. Rep. 10(5), 398-404 (2008).
    • (2008) Curr. Rheumatol. Rep. , vol.10 , Issue.5 , pp. 398-404
    • Gaddy, D.1    Robbins, P.2
  • 89
    • 84903986902 scopus 로고    scopus 로고
    • A sight on the current nanoparticle-based gene delivery vectors
    • Dizaj SM, Jafari S, Khosroushahi AY. A sight on the current nanoparticle-based gene delivery vectors. Nanoscale Res. Lett. 9(1), 252-252 (2014).
    • (2014) Nanoscale Res. Lett. , vol.9 , Issue.1 , pp. 252-252
    • Dizaj, S.M.1    Jafari, S.2    Khosroushahi, A.Y.3
  • 90
    • 81255179346 scopus 로고    scopus 로고
    • Nanoparticles in gene therapy: Principles, prospects, and challenges
    • Antonio V (Ed.). Academic Press, CA, USA
    • Liu C, Zhang N. Nanoparticles in gene therapy: principles, prospects, and challenges. In: Progress in Molecular Biology and Translational Science. Antonio V (Ed.). Academic Press, CA, USA, 509-562 (2011).
    • (2011) Progress in Molecular Biology and Translational Science , pp. 509-562
    • Liu, C.1    Zhang, N.2
  • 92
    • 69249150822 scopus 로고    scopus 로고
    • A Nanoparticle system specifically designed to deliver short interfering RNA inhibits tumor growth in vivo
    • Yagi N, Manabe I, Tottori T et al. A Nanoparticle system specifically designed to deliver short interfering RNA inhibits tumor growth in vivo. Cancer Res. 69(16), 6531-6538 (2009).
    • (2009) Cancer Res. , vol.69 , Issue.16 , pp. 6531-6538
    • Yagi, N.1    Manabe, I.2    Tottori, T.3
  • 93
    • 0030763774 scopus 로고    scopus 로고
    • How TRAIL kills cancer cells, but not normal cells
    • Gura T. How TRAIL kills cancer cells, but not normal cells. Science 277(5327), 768 (1997).
    • (1997) Science , vol.277 , Issue.5327 , pp. 768
    • Gura, T.1
  • 94
    • 84902057555 scopus 로고    scopus 로고
    • Apoptosis in cancer: Mechanisms, deregulation, and therapeutic targeting
    • Neidle S (Ed.). Academic Press, CA, USA
    • Siddik ZH. apoptosis in cancer: mechanisms, deregulation, and therapeutic targeting. In: Cancer Drug Design and Discovery (2nd Edition). Neidle S (Ed.). Academic Press, CA, USA, 357-390 (2014).
    • (2014) Cancer Drug Design and Discovery (2nd Edition) , pp. 357-390
    • Siddik, Z.H.1
  • 95
    • 84921677208 scopus 로고    scopus 로고
    • Two deathinducing human TRAIL receptors to target in cancer: Similar or distinct regulation and function?
    • Van Roosmalen IaM, Quax WJ, Kruyt FaE. Two deathinducing human TRAIL receptors to target in cancer: similar or distinct regulation and function? Biochem. Pharmacol. 91(4), 447-456 (2014).
    • (2014) Biochem. Pharmacol. , vol.91 , Issue.4 , pp. 447-456
    • Van Roosmalen Ia, M.1    Quax, W.J.2    Kruyt FaE.3
  • 97
    • 33748100542 scopus 로고    scopus 로고
    • The clinical trail of TRAIL
    • Duiker EW, Mom CH, De Jong S et al. The clinical trail of TRAIL. Eur. J. Cancer 42(14), 2233-2240 (2006).
    • (2006) Eur. J. Cancer , vol.42 , Issue.14 , pp. 2233-2240
    • Duiker, E.W.1    Mom, C.H.2    De Jong, S.3
  • 98
    • 65449152836 scopus 로고    scopus 로고
    • Following TRAIL's path in the immune system
    • Falschlehner C, Schaefer U, Walczak H. Following TRAIL's path in the immune system. Immunology 127(2), 145-154 (2009).
    • (2009) Immunology , vol.127 , Issue.2 , pp. 145-154
    • Falschlehner, C.1    Schaefer, U.2    Walczak, H.3
  • 99
    • 38649123297 scopus 로고    scopus 로고
    • RGD-avidin-biotin pretargeting to ?V?3 integrin enhances the proapoptotic activity of TNF? Related apoptosis inducing ligand (TRAIL)
    • Tarrus M, Sloot A, Temming K et al. RGD-avidin-biotin pretargeting to ?v?3 integrin enhances the proapoptotic activity of TNF? related apoptosis inducing ligand (TRAIL). Apoptosis 13(2), 225-235 (2008).
    • (2008) Apoptosis , vol.13 , Issue.2 , pp. 225-235
    • Tarrus, M.1    Sloot, A.2    Temming, K.3
  • 100
    • 84898788471 scopus 로고    scopus 로고
    • Nanomedicines: Addressing the scientific and regulatory gap
    • Tinkle S, Mcneil SE, Mühlebach S et al. Nanomedicines: addressing the scientific and regulatory gap. Ann. NY Acad. Sci. 1313(1), 35-56 (2014).
    • (2014) Ann. NY Acad. Sci. , vol.1313 , Issue.1 , pp. 35-56
    • Tinkle, S.1    Mcneil, S.E.2    Mühlebach, S.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.